Skip to main
MGTX

MGTX Stock Forecast & Price Target

MGTX Analyst Ratings

Based on 7 analyst ratings
Strong Buy
Strong Buy 57%
Buy 43%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

MeiraGTx Holdings is a promising company due to its vertically integrated structure which gives them control over all stages of development, including manufacturing. With a strong pipeline targeting high unmet needs and partnerships such as the one with Hologen for their Parkinson's program, the company has the potential for significant growth. While there are risks, such as delays in clinical trials and competition, we believe the company's low discount rate and conservative growth rate indicate a positive long-term outlook for investors.

Bears say

MeiraGTx Holdings is a clinical-stage biotech company that is focused on developing genetic medicines for diseases with high unmet needs. Despite having in-house manufacturing capabilities, a proprietary platform, and a potential commercial product in RPGR-associated XLRP, the company's inconsistent data and regulatory uncertainties pose a significant risk to its future success and potential profitability. Additionally, the company's reliance on non-dilutive financing and its lack of revenue-generating products make it a highly speculative investment.

MGTX has been analyzed by 7 analysts, with a consensus rating of Strong Buy. 57% of analysts recommend a Strong Buy, 43% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of MeiraGTx Holdings plc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About MeiraGTx Holdings plc (MGTX) Forecast

Analysts have given MGTX a Strong Buy based on their latest research and market trends.

According to 7 analysts, MGTX has a Strong Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

MeiraGTx Holdings plc (MGTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.